FDA Approved: BYOOVIZ — Original Application (BIOGEN INC.)

View source ↗

Summary

BYOOVIZ, Biogen's ranibizumab-nuna biosimilar, has been approved by the FDA through its Original Application, with indications matching those of the reference r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Macular Edema Following Branch Retinal Vein Occlusion
• Macular Edema Following Central Retinal Vein Occlusion
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BYOOVIZ (ranibizumab-nuna)

Snippet

ORIG AP for BYOOVIZ (RANIBIZUMAB-NUNA)